New pharmacological strategies for augmenting extinction learning in anxiety disorders

New pharmacological strategies for augmenting extinction learning in anxiety disorders AbstractDespite advances in the treatment of fear-, anxiety- and trauma-related disorders, a considerable proportion of patients shows only partial long-term therapeutic benefit with existing treatments. A promising option in improving therapy is speeding up and boosting the effect of exposure-based therapy (EBT) by pharmacological interventions. Here, we will discuss select examples of novel concepts in augmenting fear extinction, the central mechanisms of EBT. Based on accumulating knowledge from animal and human studies concerning the neurocircuitries and neurobiological mechanisms underlying successful fear extinction, diverse potential pharmacological targets have been identified to optimize the efficacy of fear extinction. We focus here on selected examples of these targets and present translational evidence for strengthening fear inhibitory learning by using L-DOPA and D-cycloserine. Furthermore, the potential of HDAC inhibitors and microRNAs (e. g. miR-144) as epigenetic targets, as well as neuropeptide S as a model substance with combined acute anxiolytic and extinction-facilitating properties are discussed. The presented mechanisms represent promising novel strategies that may be useful in the future for augmenting the efficacy and improving the acceptance of EBT in the treatment of anxiety disorders, although further work remains to be done in characterising the underlying modes of action and safety aspects. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neuroforum de Gruyter

New pharmacological strategies for augmenting extinction learning in anxiety disorders

Loading next page...
 
/lp/degruyter/new-pharmacological-strategies-for-augmenting-extinction-learning-in-7HVo3IUuHV
Publisher
De Gruyter
Copyright
© 2017 by De Gruyter
ISSN
1868-856X
eISSN
1868-856X
D.O.I.
10.1515/nf-2017-A011
Publisher site
See Article on Publisher Site

Abstract

AbstractDespite advances in the treatment of fear-, anxiety- and trauma-related disorders, a considerable proportion of patients shows only partial long-term therapeutic benefit with existing treatments. A promising option in improving therapy is speeding up and boosting the effect of exposure-based therapy (EBT) by pharmacological interventions. Here, we will discuss select examples of novel concepts in augmenting fear extinction, the central mechanisms of EBT. Based on accumulating knowledge from animal and human studies concerning the neurocircuitries and neurobiological mechanisms underlying successful fear extinction, diverse potential pharmacological targets have been identified to optimize the efficacy of fear extinction. We focus here on selected examples of these targets and present translational evidence for strengthening fear inhibitory learning by using L-DOPA and D-cycloserine. Furthermore, the potential of HDAC inhibitors and microRNAs (e. g. miR-144) as epigenetic targets, as well as neuropeptide S as a model substance with combined acute anxiolytic and extinction-facilitating properties are discussed. The presented mechanisms represent promising novel strategies that may be useful in the future for augmenting the efficacy and improving the acceptance of EBT in the treatment of anxiety disorders, although further work remains to be done in characterising the underlying modes of action and safety aspects.

Journal

Neuroforumde Gruyter

Published: Nov 27, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial